Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a
provider of quality assurance software under the PrintRite3D®
brand, today announced financial results for the three and six
months ended June 30, 2017 and provided an overview of recent
developments.
Second Quarter 2017 Business Highlights
and Recent Developments
- August 2017 – Sigma Labs announced that its cloud-based
PrintRite3D® INSPECT® software Version 2.0 was installed at
Woodward Inc. (NASDAQ:WWD) Aircraft Turbine Systems group at its
Zeeland, MI location. The Company's PrintRite3D® software is part
of Woodward's additive manufacturing strategies to ensure that
Woodward's aerospace and industrial customers receive quality
product.
- August 2017 – Sigma Labs announced signing Jeta Enterprises as
a new manufacturer’s representative for sales of Sigma Labs
contract printing and additive manufacturing (AM) services in the
Pacific Northwest region of the U.S, including Oregon and
Washington states. Jeta’s strong customer base in Aerospace and
Medical Devices coupled with its expertise in custom-engineered
components positions it to serve a growing base of demand for
advanced component manufacturing.
- July 2017 – Sigma Labs announced that Mark Cola was appointed
as Sigma Labs’ Chief Technology Officer on July 24, 2017,
responsible for building and implementing the Sigma Labs
technological strategy and guiding key technical advancements
towards digitalization in the context of the Industrial Internet of
Things (IIoT). Mr. Cola formerly served as President and CEO of
Sigma Labs and his new title is President and Chief Technology
Officer. Mr. Cola will seek to expand and grow the Company through
next-generation products and key customer development in a broad
range of industries.
- July 2017 - John Rice, who has served as Chairman of the Board
of the Company since his appointment in April 2017, replaced Mr.
Cola as CEO. As Chairman and interim CEO, Mr. Rice will oversee
Sigma Labs' implementation of internal and external growth, with an
emphasis on internal focus technology, sales, and efficiency, and
externally, reaching into the marketplace to expand the Company’s
digital technical bandwidth with respect to the Company's
In-Process Quality Assurance™ (“IPQA®”) technology and AM. Mr. Rice
brings substantial operating and investment experience to these
tasks, including with respect to operations of startup and emerging
companies, corporate finance, and mergers and acquisitions.
- July 2017 – Sigma Labs announced the June 30, 2016 publication
of its U.S. Patent Application No. US 2016/0185048; Multi-Sensor
Quality Inference and Control for Additive Manufacturing Processes.
This patent application is related to real-time quality analysis
during AM processes and the characterization of material properties
using acoustic signals emitted during AM which can be used in
addition to optical signals to simplify the qualification of
printed parts.
- July 2017 – Sigma Labs announced that it signed a Technology
Development Agreement (TDA) with OXYS Corporation, a technology
company in Cambridge, MA working in the Industrie 4.0 space.
The first project to be executed under the TDA will be a new
architecture platform for the Company's PrintRite3D® INSPECT.
- June 2017 – Sigma Labs announced that its PrintRite3D® INSPECT®
software Version 2.0 was installed at Honeywell Aerospace in
Honeywell's Advanced Manufacturing Engineering Center in Phoenix,
AZ, in connection with Sigma Labs' ongoing participation in the
Honeywell lead, DARPA Phase III.
- June 2017 – Sigma Labs announced that the Company entered into
agreements with two additional, non-exclusive sales agents in the
Asia Pacific region, driven by strong customer interest in the
region for PrintRite3D®. One such agent, Enervision Inc., will
target the high growth expectations in the South Korean AM market,
driven by the Korean government's announcement in April 2017 of a
$37 million investment to accelerate the development of 3D printing
across the country. Sigma Labs' other new sales agent,
Beijing Yida Sifang Technology Co., Ltd, a leading metal AM
reseller with multiple offices in China, will assist Sigma Labs
with its expansion into the China AM market.
“We are implementing our strategic double down
on both Sigma Labs' technology and also on our ongoing efforts to
grow Sigma Labs into a robust digital 3D ecosystem by seeking to
identify compatible businesses to potentially acquire that will be
synergistic with Sigma Labs' technology and business, although
there are currently no agreements with respect to the acquisition
by the Company of any third party, and there is no assurance than
any acquisition will be consummated. In July and early August 2017,
we changed our management lineup to add more capacity to implement
our strategy. We believe that we have excellent technology and are
supported by an excellent team of technologists. We also believe
that we have accomplished a hard-won understanding of a rapidly
changing market place, and that our early adopter and OEM
strategies are gaining traction. We know that we need to perform
better operationally, and are reconstituting senior management and
the Board to focus on three very defined targets: (1) product
development, sales, and support; (2) business operations; and (3)
expansion through the exploration of various business
opportunities," said John Rice, interim CEO.
Second Quarter Ended June 30, 2017
Financial Results
Revenue for the three months ended June 30,
2017, was $290,553, as compared to revenue of $93,824 during the
same period in 2016. The increase in revenue was primarily due to
new contracts in 2017, including Honeywell DARPA Phase III, Aerojet
Rocketdyne, and Solar Turbines, Pratt and Whitney, and Woodward
which accounted for the majority of the $196,729 increase in
revenues when comparing Q2 2017 to Q2 2016. In addition, the Q2
2016 revenues were lower due to the completion of the GEA America
Makes Program in Q1 2016, providing no revenues from that contract
in Q2 2016.
General and Administrative expenses for the
three months ended June 30, 2017, were $594,193, as compared to
$480,697 for the same period in 2016. The $113,496 increase
was primarily due to increases in legal fees and the increase in
interest and finance costs on the $1,000,000 promissory note
originated in October 2016. Payroll expenses for the three months
ended June 30, 2017, were $300,661, as compared to $252,895 for the
same period in 2016. The $47,766 increase was due to an increase in
employees in Q2 2017 versus Q2 2016. Expenses relating to
stock-based compensation for the three months ended June 30, 2017,
were $166,773, as compared to $59,362 for the same period in 2016.
The $107,411 increase was due to more stock and stock options being
used to pay for services as a mechanism to preserve cash. Research
and Development expenses for the three months ended June 30, 2017,
were $118,853, as compared to $11,907 for the same period in 2016.
The $106,946 increase was the result of continued improvement and
development of the Company's software and technology.
Net loss for the three months ended June 30,
2017 increased $246,895 and totaled $988,741, as compared to
$741,846 for the same period in 2016. The increase is primarily due
to the $375,619 increase in expenses noted above, partially offset
by the $116,221 increase in gross profits, which is primarily due
to the $196,729 increase in revenues in Q2 2017 compared to Q2
2016.
Revenue for the six months ended June 30, 2017,
was $440,756, as compared to $452,279 recognized during the same
period in 2016. The $11,523 decrease in revenue was primarily due
to the completion of the GEA America Makes Program in 2016,
providing three months of revenue in 2016 but no revenue in 2017.
However, new business in Q2 2017 from customers like Honeywell
DARPA Phase III, Aerojet Rocketdyne and Solar Turbines made up for
the majority of the reduction that resulted from the completion of
the GEA America Makes Program. The Company financed its operations
during the six months ended June 30, 2017 and 2016 primarily from
PrintRite3D® system sales, DARPA Phase III, Aerojet Rocketdyne and
Solar Turbines programs, engineering consulting services provided
to third parties, and through sales of the Company's common stock
and debt securities.
General and Administrative expenses for the six
months ended June 30, 2017, were $1,237,988, as compared to
$876,185 for the same period in 2016. The costs of the February
2017 public offering that generated net proceeds of approximately
$5.25 million, legal fees, and the interest and finance costs
related to the Company's $1,000,000 note, are the primary reasons
for the $361,803 increase in G&A expenses. Payroll expenses for
the six months ended June 30, 2017, were $677,282, as compared to
$468,484 for the same period in 2016. Employee additions are the
main reason for the $208,798 payroll expense increase. Expenses
relating to stock-based compensation for the six months ended June
30, 2017, were $306,405, as compared to $130,913 for the same
period in 2016. The $175,492 increase is the result of using stock
and stock options to pay for services in order to preserve cash.
Research and Development expenses for the six months ended June 30,
2017, were $167,615, as compared to $50,978 for the same period in
2016. The $116,637 increase is the result of increased efforts to
continue to develop and improve the Company's software and
technology.
Net loss for the six months ended June 30, 2017,
increased $720,193 over the prior year and totaled $1,932,706 as
compared to $1,212,513 for the same period in 2016. While revenue
decreased $11,523, the Company experienced an $862,730 net increase
in expenses. The Company recorded other income of $201,774,
primarily from the receipt of New Mexico state employee incentives,
and non-cash income and expenses related to derivative liabilities
and debt discounts.
As of June 30, 2017, the Company had $3,384,499
in cash on its balance sheet, compared to $398,391 in cash as of
June 30, 2016 and a working capital surplus of $3,374,359 as of
June 30, 2017, compared to a working capital surplus of $110,799 as
of June 30, 2016.
Investor Conference
CallManagement will host a conference call today, Monday,
August 14, 2017 at 4:30pm to review financial results and corporate
highlights. Following management’s formal remarks, there will be a
question and answer session. To listen to the call by phone,
interested parties within the U.S. should call 1-877-344-7529 and
International callers should call 1-412-317-5134. All callers
should ask for the Sigma Labs conference call. The conference call
will also be available through a live webcast at
www.sigmalabsinc.com. Details for the webcast may be found on the
Company’s IR events page at
http://client.irwebkit.com/sigmalabsinc/events. A replay of the
call will be available approximately one hour after the end of the
call through September 14, 2017. The replay can be accessed via
Sigma Labs' website or by dialing 877-344-7529 (domestic) or
412-317-0088 (international) or Canada Toll Free at 855-669-9658.
The replay conference ID number is 10111326. The webcast replay
will be available through November 14, 2017.
About Sigma Labs, Inc. Sigma
Labs, Inc. is a provider of quality assurance software under the
PrintRite3D® brand and a developer of advanced, in-process,
non-destructive quality assurance software for commercial firms
worldwide seeking productive solutions for advanced manufacturing.
For more information please visit us at www.sigmalabsinc.com.
Forward-Looking StatementsThis
press release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
(which Sections were adopted as part of the Private Securities
Litigation Reform Act of 1995). Statements preceded by, followed by
or that otherwise include the words “believe,” “anticipate,”
“estimate,” “expect,” “intend,” “plan,” “project,” “prospects,”
“outlook,” and similar words or expressions, or future or
conditional verbs such as “will,” “should,” “would,” “may,” and
“could” are generally forward-looking in nature and not historical
facts. These forward-looking statements involve known and unknown
risks, uncertainties and other factors which may cause the
Company's actual results, performance or achievements to be
materially different from any anticipated results, performance or
achievements. The Company disclaims any intention to, and
undertakes no obligation to, revise any forward-looking statements,
whether as a result of new information, a future event, or
otherwise. For additional risks and uncertainties that could impact
the Company’s forward-looking statements, please see the Company’s
Annual Report on Form 10-K (including but not limited to the
discussion under “Risk Factors” therein) filed with the SEC on
March 31, 2017 and which may be viewed at http://www.sec.gov.
Sigma Labs, Inc. |
Condensed Balance Sheets |
(Unaudited) |
|
|
|
|
|
|
|
June 30, 2017 |
|
December 31, 2016 |
|
|
|
|
|
ASSETS |
|
|
|
Current Assets: |
|
|
|
|
Cash |
$ |
3,384,499 |
|
|
$ |
398,391 |
|
|
Accounts
Receivable, net |
|
235,467 |
|
|
|
288,236 |
|
|
Note
Receivable, net |
|
762,034 |
|
|
|
- |
|
|
Inventory |
|
227,827 |
|
|
|
187,241 |
|
|
Prepaid
Assets |
|
37,176 |
|
|
|
36,056 |
|
Total Current Assets |
|
4,647,003 |
|
|
|
909,924 |
|
|
|
|
|
|
Other Assets: |
|
|
|
|
Property
and Equipment, net |
|
491,188 |
|
|
|
564,933 |
|
|
Intangible Assets, net |
|
241,978 |
|
|
|
226,450 |
|
|
Investment in Joint Venture |
|
500 |
|
|
|
500 |
|
|
Prepaid
Stock Compensation |
|
111,070 |
|
|
|
167,562 |
|
Total Other Assets |
|
844,736 |
|
|
|
959,445 |
|
|
|
|
|
|
TOTAL ASSETS |
$ |
5,491,739 |
|
|
$ |
1,869,369 |
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current Liabilities: |
|
|
|
|
Accounts
Payable |
|
137,605 |
|
|
|
112,175 |
|
|
Notes
Payable, net of original issue discount $30,297 atJune 30, 2017 and
net of original issue discount$69,703 and net of debt discount
$358,280 atDecember 31, 2016 |
|
969,703 |
|
|
|
561,834 |
|
|
Accrued
Expenses |
|
165,336 |
|
|
|
125,116 |
|
Total Current Liabilities |
|
1,272,644 |
|
|
|
799,125 |
|
Long-Term Liabilities |
|
|
|
|
Derivative Liability |
|
- |
|
|
|
93,206 |
|
Total Long-Term Liability |
|
- |
|
|
|
93,206 |
|
|
|
|
|
|
TOTAL LIABILITIES |
|
1,272,644 |
|
|
|
892,331 |
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
Preferred Stock, $0.001 par; 10,000,000 sharesauthorized; |
|
|
|
|
None issued and
outstanding |
|
- |
|
|
|
- |
|
Common Stock, $0.001 par; 7,500,000 sharesauthorized; |
|
|
|
|
4,570,199 and
3,133,789 issued and outstanding at June 30, 2017 and 2016,
respectively |
|
4,570 |
|
|
|
3,135 |
|
|
Additional
Paid-In Capital |
|
15,908,185 |
|
|
|
10,734,857 |
|
|
Accumulated
Deficit |
|
(11,693,660 |
) |
|
|
(9,760,954 |
) |
Total Stockholders' Equity |
|
4,219,095 |
|
|
|
977,038 |
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
$ |
5,491,739 |
|
|
$ |
1,869,369 |
|
|
|
|
|
|
Sigma Labs, Inc. |
Condensed Statements of
Operations |
(Unaudited) |
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
|
June 30,2017 |
June 30,2016 |
June 30,2017 |
June 30,2016 |
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
290,553 |
|
$ |
93,824 |
|
$ |
440,756 |
|
$ |
452,279 |
|
|
|
|
|
|
COST OF
REVENUE |
$ |
111,412 |
|
|
30,904 |
|
|
185,946 |
|
|
138,485 |
|
|
|
|
|
|
GROSS
PROFIT |
|
179,141 |
|
|
62,920 |
|
|
254,810 |
|
|
313,794 |
|
|
|
|
|
|
EXPENSES: |
|
|
|
|
Other General
and Administration |
|
594,193 |
|
|
480,697 |
|
|
1,237,988 |
|
|
876,185 |
|
Payroll
Expense |
|
300,661 |
|
|
252,895 |
|
|
677,282 |
|
|
468,484 |
|
Stock-Based
Compensation |
|
166,773 |
|
|
59,362 |
|
|
306,405 |
|
|
130,913 |
|
Research and
Development |
|
118,853 |
|
|
11,907 |
|
|
167,615 |
|
|
50,978 |
|
Total
Expenses |
|
1,180,480 |
|
|
804,861 |
|
|
2,389,290 |
|
|
1,526,560 |
|
|
|
|
|
|
OTHER INCOME
(EXPENSE) |
|
|
|
|
Interest
Income |
|
12,598 |
|
|
95 |
|
|
12,941 |
|
|
253 |
|
Other
Income |
|
- |
|
|
- |
|
|
152,068 |
|
|
- |
|
Other
Income-Decrease in fair value of derivative liabilities |
|
- |
|
|
- |
|
|
93,206 |
|
|
- |
|
Other Expense -
Debt discount amortization |
|
- |
|
|
- |
|
|
(56,441 |
) |
|
- |
|
Total
Other Income |
|
12,598 |
|
|
95 |
|
|
201,774 |
|
|
253 |
|
|
|
|
|
|
LOSS BEFORE
PROVISION FOR INCOME TAXES |
|
(988,741 |
) |
|
(741,846 |
) |
|
(1,932,706 |
) |
|
(1,212,513 |
) |
|
|
|
|
|
Provision for
income Taxes |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
|
|
|
|
Net
Loss |
$ |
(988,741 |
) |
$ |
(741,846 |
) |
$ |
(1,932,706 |
) |
$ |
(1,212,513 |
) |
|
|
|
|
|
Net Loss per
Common Share - Basic and Diluted |
$ |
(0.22 |
) |
$ |
(0.24 |
) |
$ |
(0.46 |
) |
$ |
(0.38 |
) |
|
|
|
|
|
Weighted
Average Number of Shares |
|
|
|
|
Outstanding - Basic and Diluted |
|
4,570,199 |
|
|
3,117,851 |
|
|
4,207,116 |
|
|
3,117,851 |
|
|
|
|
|
|
|
Sigma Labs, Inc. |
|
Condensed Statements of Cash
Flows |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
Six Months ended |
|
|
|
|
2017 |
|
|
|
2016 |
|
|
|
|
|
|
|
OPERATING ACTIVITIES |
|
|
|
|
Net
Loss |
$ |
(1,932,706 |
) |
|
$ |
(1,212,513 |
) |
|
Adjustments to reconcile Net Income (Loss) to Net Cashused
in operating activities: |
|
|
|
|
Noncash Expenses: |
|
|
|
|
|
Amortization |
|
6,526 |
|
|
|
5,764 |
|
|
|
Depreciation |
|
85,125 |
|
|
|
87,054 |
|
|
|
Stock
Compensation |
|
307,445 |
|
|
|
130,913 |
|
|
|
Loss on
Joint Venture |
|
- |
|
|
|
103 |
|
|
|
Revaluation of derivative liability and debt discount related
tonotes payable |
|
(93,206 |
) |
|
|
- |
|
|
|
Note
payable original issue discount |
|
49,589 |
|
|
|
- |
|
|
|
Note
payable debt discount amortization |
|
56,441 |
|
|
|
- |
|
|
Change in assets and liabilities: |
|
|
|
|
|
Accounts
Receivable |
|
52,769 |
|
|
|
27,564 |
|
|
|
Inventory |
|
(40,586 |
) |
|
|
(70,765 |
) |
|
|
Prepaid
Assets |
|
(1,120 |
) |
|
|
7,344 |
|
|
|
Accounts
Payable |
|
25,430 |
|
|
|
63,974 |
|
|
|
Accrued
Expenses |
|
40,220 |
|
|
|
46,006 |
|
|
NET CASH USED IN OPERATING
ACTIVITIES |
|
(1,444,073 |
) |
|
|
(914,556 |
) |
|
|
|
|
|
|
INVESTING ACTIVITIES |
|
|
|
|
|
Purchase
of Furniture and Equipment |
|
(11,380 |
) |
|
|
(25,430 |
) |
|
|
Purchase
of Intangible Assets |
|
(22,054 |
) |
|
|
(46,835 |
) |
|
|
Notes
receivable |
|
(762,034 |
) |
|
|
- |
|
|
NET CASH USED IN INVESTING
ACTIVITIES |
|
(795,468 |
) |
|
|
(72,265 |
) |
|
|
|
|
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
Proceeds
from issuance of common stock and warrants |
|
5,225,649 |
|
|
|
- |
|
|
NET CASH PROVIDED BY FINANCING
ACTIVITIES |
|
5,225,649 |
|
|
|
- |
|
|
|
|
|
|
|
NET
CASH DECREASE FOR PERIOD |
|
2,986,108 |
|
|
|
(986,821 |
) |
|
|
|
|
|
|
CASH AT BEGINNING OF PERIOD |
|
398,391 |
|
|
|
1,539,809 |
|
|
|
|
|
|
|
CASH AT END OF PERIOD |
$ |
3,384,499 |
|
|
$ |
552,988 |
|
|
|
|
|
|
|
Supplemental Disclosure of Cash Flow
Information: |
|
|
|
|
|
Cash paid
during the period for: |
|
|
|
|
|
Interest |
$ |
50,418 |
|
|
$ |
- |
|
|
|
Income Taxes |
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
Supplemental Schedule of Noncash Investing and Financing
Activities: |
|
|
|
|
Issuance
of Common Stock for services |
$ |
51,408 |
|
|
$ |
44,998 |
|
|
|
|
|
|
|
Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
brets@coreir.com
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2023 to Apr 2024